Evidence map›Paper›PMID 37994361›Full record

ArticleGates open research2022

Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study.

Hannah Hussey, Mary-Ann Davies, Alexa Heekes, Carolyn Williamson, Ziyaad Valley-Omar, Diana Hardie, Stephen Korsman, Deelan Doolabh, Wofgang Preiser, Tongai Maponga and 15 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gates open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 2 countries.

Hannah HusseyHealth Intelligence, Western Cape Government: Health, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-6199-0904
Mary-Ann DaviesHealth Intelligence, Western Cape Government: Health, Cape Town, South Africa.
Alexa HeekesHealth Intelligence, Western Cape Government: Health, Cape Town, South Africa.
Carolyn WilliamsonDivision of Medical Virology, University of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0003-0125-1226
Ziyaad Valley-OmarDivision of Medical Virology, University of Cape Town, Cape Town, South Africa.
Diana HardieDivision of Medical Virology, University of Cape Town, Cape Town, South Africa.
Stephen KorsmanDivision of Medical Virology, University of Cape Town, Cape Town, South Africa.
Deelan DoolabhDivision of Medical Virology, University of Cape Town, Cape Town, South Africa.
Wofgang PreiserNational Health Laboratory Service, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-0254-7910
Tongai MapongaNational Health Laboratory Service, Cape Town, South Africa.
Arash IranzadehDivision of Medical Virology, University of Cape Town, Cape Town, South Africa.
Susan EngelbrechtNational Health Laboratory Service, Cape Town, South Africa.
Sean WassermanWellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Neshaad SchruederDepartment of Medicine, Tygerberg Hospital,, Stellenbosch University, Cape Town, South Africa.
Linda BolokoWellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Greg SymonsDepartment of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Peter RaubenheimerDepartment of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-5416-1286
Abraham ViljoenDepartment of Medicine, Tygerberg Hospital,, Stellenbosch University, Cape Town, South Africa.
Arifa ParkerDepartment of Medicine, Tygerberg Hospital,, Stellenbosch University, Cape Town, South Africa.
Cheryl CohenNational Institute for Communicable Diseases, Johannesburg, South Africa.
Waasila JasatNational Institute for Communicable Diseases, Johannesburg, South Africa.
Richard LessellsKwaZulu-Natal Research, Innovation & Sequencing Platform, University of KwaZulu Natal, Durban, South Africa.
Robert J WilkinsonWellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-2753-1800
Andrew BoulleHealth Intelligence, Western Cape Government: Health, Cape Town, South Africa.
Marvin HsiaoDivision of Medical Virology, University of Cape Town, Cape Town, South Africa.
National Health Laboratory Service · ZAUniversity of Cape Town · ZAWestern Cape Department of Health · ZAStellenbosch University · ZANational Institute for Communicable DiseasesUniversity of KwaZulu-Natal · ZAUniversity of the Witwatersrand · ZA

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B.1.617.2clinical severityDeltaRdRp target delaySARS-CoV-2South Africa

Identifiers

PMID37994361
PMCPMC10663174
OpenAlexW4293802062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.